Tenaya Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
TNYA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
171 Oyster Point Blvd., Suite 500, South San Francisco, California

Insiders trading volume in the past year

Tenaya Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David V. Goeddel Director, 10%+ Owner $61.2M +$10M +19.5% Feb 12, 2024
Column Group III Gp, Lp 10%+ Owner $61.2M +$10M +19.5% Feb 12, 2024
Eli Casdin Director $25.9M Nov 17, 2022
Timothy Hoey Chief Scientific Officer $1.72M -$85.6K -4.75% Mar 5, 2024
Casdin Partners Master Fund, L.P. 10%+ Owner $1.54M Aug 3, 2021
Leone D. Patterson Chief Fin. and Bus. Officer $590K -$30.5K -4.91% Feb 23, 2024
Faraz Ali Chief Executive Officer, Director $545K -$65.5K -10.7% Aug 16, 2024
Whittemore Tingley Chief Medical Officer $310K -$59.6K -16.1% Aug 16, 2024
Chihiro Saito SVP, Accounting and Fin. Ops. $183K -$6.84K -3.6% Aug 15, 2024
JeenJoo Kang Director $107K Aug 3, 2021
Catherine Stehman-Breen Director Jun 9, 2023
Karah Parschauer Director Jun 9, 2023
Deepak Srivastava Director Jun 9, 2023
Jeffrey T. Walsh Director Jun 9, 2023
Amy L. Burroughs Director Jun 9, 2023
Jin Long Chen Director Jun 9, 2023
R. Sanders Williams Director Jun 9, 2023
June Lee Director Jun 9, 2023

Recent Insider Transactions by Companies or Individuals for Tenaya Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.